Michael Jackson biopic Michael crosses $911.9M, overtakes Bohemian Rhapsody worldwide

Michael has crossed $911.9 million worldwide, surpassing Bohemian Rhapsody as the highest-grossing music biopic of all time, with the film still rolling out internationally. The headline number is real and moving: $358.6 million at the domestic box office and $553.3 million internationally.

The key “wait, how did it get there?” detail is in the split. Universal generated $540.5 million of the international total after acquiring foreign theatrical and ancillary rights. That means the performance is not just a domestic story or a star-driven splash. It is a coordinated worldwide rollout where distribution rights decisions and timing matter just as much as the on-screen product.

Directed by Antoine Fuqua and written by John Logan, Michael is a Lionsgate and Universal co-production, with both studios operating the levers that turn an opening weekend into a global run. The film arrives in Japan today, and the industry math gets spicy from there. The article frames Japan as a potential tailwind that could push Michael past $1 billion worldwide, which would make it only the second film to cross that threshold at the 2026 global box office after Universal’s Super Mario Galaxy Movie.

Put that in executive terms: when a movie is inching toward a billion, distribution strategy shifts from “maximize per-territory performance” to “protect the global run.” The article also notes the scale of the domestic dominance, calling Michael the highest-grossing domestic biopic of all time. It also cites the largest global opening weekend ever for a music biopic, plus being the most successful biopic ever in France, surpassing La Vie en Rose. Those are not just bragging rights. They are indicators of how audiences responded across geographies, which affects how studios underwrite future slate risk.

For comparison, Bohemian Rhapsody grossed $216.6 million domestically and $694.3 million internationally for a $910.9 million global total. Freddie Mercury’s biopic won four Oscars, including Best Film Editing, and Rami Malek won Best Actor. Both movies were produced by Graham King, who, per the article, has now broken his own all-time box office record for music biopics. Translation: the market is telling a repeatable story about what works with music biopics, and the same production engine is getting it right again.

But the road to release was not clean. Lionsgate was forced to undertake $50 million in reshoots after the Jackson estate identified a key issue with a plot point in the screenplay concerning one of Jackson’s accusers, who was not meant to be dramatised in the film. That detail matters because it connects creative risk to calendar and cost. Reshoots of that magnitude can tighten release windows, add financing complexity, and introduce operational churn. Yet here we are, with the film continuing its global rollout and surpassing Bohemian Rhapsody. The second-order lesson for boards and studio leadership is brutal and practical: even when the final product lands, creative and rights friction can turn into real cash out the door.

Michael also arrives with a star story that is, in its own way, an industry decoy and an asset. The film stars Jaafar Jackson, Michael Jackson’s nephew, in the title role. The article backs up why audiences have reasons to show up with Jackson’s commercial record: an estimated 350 million records sold worldwide, 13 No. 1 singles on the Billboard Hot 100 as a solo artist including “Billie Jean,” “Beat It,” and “Black or White,” and the record best-selling album of all time with Thriller, which has sold more than 70 million copies worldwide. Thriller spent 37 weeks at No. 1 on the Billboard 200. Jackson was inducted into the Rock and Roll Hall of Fame twice, once as a member of the Jackson 5 in 1997 and once as a solo artist in 2001. That level of catalog gravity is what turns a biopic into a built-in marketing machine.

Finally, zoom out from one film to the strategic stakes for peers. The article says forty international markets surpassed Bohemian Rhapsody’s lifetime gross, including Brazil, France, and Mexico, and that this is Lionsgate’s highest-grossing theatrical release ever worldwide. For executives assessing future music-biopic investments, this is a live test case: the market can reward big-scale, globally deployable storytelling, but only after costly adjustments and rights-sensitive rewrites. If Michael reaches $1 billion, it will not just reset records. It will likely recalibrate expectations across the category, from how studios structure co-productions and foreign rights to how they budget for authenticity and legal review before filming even starts.